MARC Record from marc_columbia

LEADER: 03912cam a2200541 i 4500
001 10292527
005 20190121130927.0
008 130318s2013 dcua b 100 0 eng
010 $a 2013444474
016 7 $a101613693$2DNLM
020 $a9780309269445
020 $a030926944X
035 $a(OCoLC)830351870
035 $a(OCoLC)ocn830351870
035 $a(NNC)10292527
040 $aNLM$beng$erda$cNLM$dYDXCP$dTEF$dCGU$dCUT$dOCLCO$dDLC
042 $anlmcopyc
050 4 $aRC270.8$b.D45 2013
060 00 $a2013 G-559
060 10 $aQZ 266
082 04 $a616.99406$223
100 1 $aBalogh, Erin,$eauthor.
245 10 $aDelivering affordable cancer care in the 21st century :$bworkshop summary /$cErin Balogh, Margie Patlak, and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
264 1 $aWashington, D.C. :$bNational Academies Press,$c[2013]
300 $axiv, 80 pages :$billustrations (some color), color map ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references.
505 0 $aIntroduction -- A financial crisis in health care -- Drivers of health care costs -- Cancer care costs -- Financial burden on patients with cancer -- Questionable value -- Current challenges -- Inappropriate incentives -- Unrealistic expectations -- Overuse and misuse of interventions -- Variable care, lack of best practices, and an inadequate evidence base -- Legal and regulatory issues -- Assessing value -- Possible solutions -- Patient and clinician communication and education -- Best practices in cancer care -- Evidence base for clinical practice and reimbursement -- Financial incentives aligned with affordable, high-quality cancer care -- Delivery system and reimbursement changes -- Wrap up.
520 $a"Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness. In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop"--Publisher's description.
650 12 $aHealth Care Costs.
651 2 $aUnited States.
655 2 $aCongress.
650 12 $aNeoplasms$xtherapy.
650 22 $aEvidence-Based Medicine.
650 22 $aHealth Services$xeconomics.
650 22 $aNeoplasms$xeconomics.
650 22 $aPractice Guidelines as Topic.
650 0 $aCancer$xTreatment$vCongresses.
650 0 $aMedical care, Cost of$vCongresses.
650 0 $aMedical care$xFinance$vCongresses.
700 1 $aPatlak, Margie,$eauthor.
700 1 $aNass, Sharyl J.,$eauthor.
710 2 $aNational Cancer Policy Forum (U.S.),$esponsoring body.
710 2 $aInstitute of Medicine (U.S.).$bBoard on Health Care Services,$eissuing body.
711 2 $aDelivering Affordable Cancer Care in the 21st Century (Workshop)$d(2012 :$cWashington, D.C.)
852 00 $boff,sci$hRC270.8$i.D45 2013g